Regulation of myeloid growth and differentiation by the insulin-like growth factor I receptor.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8977425
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.

  1996cited by this paper
• Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor.

  1996cited by this paper
• The colony-stimulating factors induce expression of insulin-like growth factor-I messenger ribonucleic acid during hematopoiesis.

  1995cited by this paper
• Interferon-gamma inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level.

  1995cited by this paper
• Insulin-like growth factors and their binding proteins: biological actions.

  1995cited by this paper
• Associations between the neuroendocrine and immune systems

  1995cited by this paper
• Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol.

  1995cited by this paper
• Type I insulin-like growth factor receptor expression in different developmental stages of human thymocytes.

  1995cited by this paper
• Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid.

  1995cited by this paper
• Molecular and cellular aspects of the insulin-like growth factor I receptor.

  1995cited by this paper
• Induction of the growth inhibitor IGF-binding protein 3 by p53

  1995cited by this paper
• In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2.

  1994cited by this paper
• Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.

  1994cited by this paper
• Immunological effects of insulin‐like growth factor‐I–enhancement of immunoglobulin synthesis

  1994cited by this paper
• Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells

  1994cited by this paper
• An E2F binding sequence negatively regulates the response of the insulin-like growth factor 1 (IGF-I) promoter to simian virus 40T antigen and to serum.

  1994cited by this paper
• Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant.

  1994cited by this paper
• Oncogenes and the strategy of growth factors.

  1994cited by this paper
• Modulation of human basophil histamine release by insulin-like growth factors.

  1993cited by this paper
• Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells.

  1993cited by this paper
• Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor.

  1993cited by this paper
• Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts.

  1993cited by this paper
• Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production.

  1993cited by this paper
• Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

  1993cited by this paper
• Mechanisms generating functionally heterogeneous macrophages: chaos revisited

  1993cited by this paper
• Insulin-like growth factor-I regulates pro-B cell differentiation.

  1992cited by this paper
• Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.

  1992cited by this paper
• Pituitary epithelial cell implants reverse the accumulation of CD4-CD8- lymphocytes in thymus glands of aged rats.

  1992cited by this paper
• Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines.

  1992cited by this paper
• Insulin-like growth factors in the response to cerebral ischemia.

  1992cited by this paper
• The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells.

  1992cited by this paper
• The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulinlike growth factor 1 with its receptor

  1992cited by this paper
• Human leukemic T and B lymphoblasts produce insulin-like growth factor binding proteins 2 and 4.

  1991cited by this paper
• Insulin-like growth factor-I supports proliferation of autocrine thymic lymphoma cells with a pre-T cell phenotype.

  1990cited by this paper
• The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors.

  1990cited by this paper
• Insulin-like growth factor binding to the atypical insulin receptors of a human lymphoid-derived cell line (IM-9).

  1990cited by this paper
• Regulation of insulin-like growth factor I gene expression in the human macrophage-like cell line U937.

  1990cited by this paper
• Glutathione augments in vitro proliferative responses of lymphocytes to concanavalin A to a greater degree in old than in young rats.

  1990cited by this paper
• Expression and characterization of a functional human insulin-like growth factor I receptor.

  1988cited by this paper
• Classification of the insulin-like growth factor binding proteins into three distinct categories according to their binding specificities.

  1988cited by this paper
• Receptor binding and mitogenic effects of insulin and insulinlike growth factors I and II for human myeloid leukemic cells

  1987cited by this paper
• Human Leukemic Models of Myelomonocytic Development: A Review of the HL‐60 and U937 Cell Lines

  1985cited by this paper

• Coordinated changes in stromal and hematopoietic cells that define the perinatal to juvenile transition in the mouse thymus.

  2025cites this paper
• Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice

  2022cites this paper
• Insulin/IGF-1 signaling promotes immunosuppression via the STAT3 pathway: impact on the aging process and age-related diseases

  2021cites this paper
• Response of the porcine MYH4-promoter and MYH4-expressing myotubes to known anabolic and catabolic agents in vitro

  2021cites this paper
• Sirtuins and the prevention of immunosenescence.

  2021cites this paper
• IGF-1R Regulates the Extracellular Level of Active MMP-2, Pathological Neovascularization, and Functionality in Retinas of OIR Mouse Model

  2018cites this paper
• Inhibition of fucosylation by 2-fluorofucose suppresses human liver cancer HepG2 cell proliferation and migration as well as tumor formation

  2017cites this paper
• CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression

  2017cites this paper
• IGF-1 Regulates the Extracellular Level of Active MMP-2 and Promotes Müller Glial Cell Motility.

  2015cites this paper
• Effects of Silicon on Osteoblast Activity and Bone Mineralization of MC3T3-E1 Cells

  2013cites this paper
• Metabolism-Related Cytokine and Hormone Levels in the Serum of Patients with Myelodysplastic Syndromes

  2013cites this paper
• The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities

  2012cites this paper
• Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy

  2012cites this paper
• Implications and Potential Therapeutic Targeting of Insulin-Like Growth Factor Type 1 Receptor (IGF-IR) in Adulthood Acute Lymphoblastic Leukemia

  2012cites this paper
• Cell Division Cycle 7 Is a Novel Regulator of Transforming Growth Factor-β-induced Smooth Muscle Cell Differentiation*

  2012cites this paper
• IGFBP-3 Inhibits the Proliferation of Neural Progenitor Cells

  2011cites this paper
• Targeting IGF-I, IGFBPs and IGF-I receptor system in cancer: the current and future in breast cancer therapy.

  2011cites this paper
• Cyclical regulation of the insulin-like growth factor binding protein 3 gene in response to 1 α , 25-dihydroxyvitamin

  2009cites this paper
• Dried plum polyphenols attenuate the detrimental effects of TNF-alpha on osteoblast function coincident with up-regulation of Runx2, Osterix and IGF-I.

  2009cites this paper
• The Protein Kinase C (PKC) Family of Proteins in Cytokine Signaling in Hematopoiesis

  2007cites this paper
• Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells

  2006cites this paper
• Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway.

  2006cites this paper
• Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis

  2006cites this paper
• Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer.

  2005cites this paper
• 24p3 in differentiation of myeloid cells

  2005cites this paper
• Characterization of a Novel Positive Transcription Regulatory Element That Differentially Regulates the Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Gene in Senescent Cells*

  2005cites this paper
• Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.

  2004cites this paper
• Differentiation of Murine Myeloid Cells Factor in the Proliferation and Role of Pescadillo and Upstream Binding

  2004cites this paper
• From hormones to immunity: the physiology of immunology.

  2004cites this paper
• Tumor necrosis factor alpha inhibits insulin-like growth factor I-induced hematopoietic cell survival and proliferation.

  2004cites this paper
• Anti-insulin-like growth factor strategies in breast cancer.

  2004cites this paper
• Role of Pescadillo and Upstream Binding Factor in the Proliferation and Differentiation of Murine Myeloid Cells

  2004cites this paper
• Epidemiology and Biology of Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) as an Anti-cancer Molecule

  2003cites this paper
• The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells.

  2003cites this paper
• Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions.

  2003cites this paper
• IGF-I induces vascular endothelial growth factor in human mesangial cells via a Src-dependent mechanism.

  2003cites this paper
• Cell differentiation and proliferation--simultaneous but independent?

  2003cites this paper
• Epidermal growth factor—induced activation of the insulin‐like growth factor I receptor in rat hepatocytes

  2002cites this paper
• Antagonism between interleukin 3 and erythropoietin in mice with azidothymidine-induced anemia and in bone marrow endothelial cells.

  2002cites this paper
• Expression of insulin-like growth factors IGF-I and IGF-II, and their receptors during the growth and megakaryocytic differentiation of K562 cells.

  2002cites this paper
• Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.

  2002cites this paper
• Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells.

  2002influential citation
• Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization

  2001cites this paper
• Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia.

  2001cites this paper
• Involvement of insulin-like growth factors in early T cell development: a study using fetal thymic organ cultures.

  2000cites this paper
• Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis

  2000cites this paper
• Relationships between blood viscosity and insulin‐like growth factor I status in athletes

  2000cites this paper
• P53 and IGFBP-3: apoptosis and cancer protection.

  2000cites this paper
• Developmental Expression of Insulin Receptor Substrate-2 During Dimethylsulfoxide-Induced Differentiation of Human HL-60 Cells1

  2000cites this paper
• The Immune-Endocrine Loop during Aging: Role of Growth Hormone and Insulin-Like Growth Factor-I

  1999cites this paper
• Cellular Actions of Insulin-Like Growth Factor Binding Proteins

  1999cites this paper
• Elevated Cyclin E Levels, Inactive Retinoblastoma Protein, and Suppression of the p27KIP1 Inhibitor Characterize Early Development of Promyeloid Cells into Macrophages

  1999cites this paper
• Novel aspects of the insulin-like growth factor binding proteins.

  1999cites this paper
• Growth Hormone

  1999cites this paper
• Cells Dimethylsulfoxide-Induced Differentiation of Receptor Substrate-2 During Developmental Expression of Insulin

  1999cites this paper
• Insulin-Like Growth Factor Binding Proteins: New Proteins, New Functions

  1999cites this paper
• Activation of protein kinase C-zeta and phosphatidylinositol 3'-kinase and promotion of macrophage differentiation by insulin-like growth factor-I.

  1998cites this paper
• The Haematopoietic Effects of Growth Hormone and Insulin-like Growth Factor-I

  1998cites this paper
• Growth Factor-I Macrophage Differentiation by Insulin-Like-Kinase and Promotion of ′ Phosphatidylinositol 3 and ζ Activation of Protein Kinase C -

  1998influential citation
• Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding.

  1998cites this paper
• A cell-based potency assay for insulin-like growth factor-I.

  1998cites this paper
• IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors.

  1997cites this paper
• Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis

  1997cites this paper
• Insulin-like growth factor I (IGF-I) receptor overexpression abolishes the IGF requirement for differentiation and induces a ligand-dependent transformed phenotype in C2 inducible myoblasts.

  1997cites this paper
• Activation of phosphatidylinositol 3'-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes.

  1997cites this paper
• Localization of IGF-I and IGF-I receptor mRNA in Sparus aurata larvae.

  1997cites this paper